{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:32Z","timestamp":1785575732188,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Cardiovascular Research Fund"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H03309"],"award-info":[{"award-number":["21H03309"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although intravenous diuretics is a cornerstone of acute heart failure treatment (AHF), its optimal initial dose is unclear. This is a <jats:italic>post-hoc<\/jats:italic> analysis of the REALITY-AHF, a prospective multicentre observational registry of AHF. The initial intravenous diuretic dose used in each patient was categorised into below, standard, or above the recommended dose groups according to guideline-recommended initial intravenous diuretic dose. The recommended dose was individualised based on the oral diuretic dose taken at admission. We compared the study endpoints, including 60-day mortality, diuretics response within six hours, and length of hospital stay (HS). Of 1093 patients, 429, 558, and 106 were assigned to the Below, Standard, and Above groups, respectively. The diuretics response and HS were significantly greater in the Below group than in the Standard group after adjusting for covariates. Kaplan\u2013Meier analysis indicated a significantly higher incidence of 60-day mortality in the Above group than the Standard group. This difference was retained after adjusting for other prognostic factors. Treatment with a lower than guideline-recommended intravenous diuretic dose was associated with longer HS, whereas above the guideline-recommended dose was associated with a higher 60-day mortality rate. Our results reconfirm that the guideline-recommended initial intravenous diuretic dose is feasible for AHF.<\/jats:p>","DOI":"10.1038\/s41598-022-06032-x","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T11:04:34Z","timestamp":1644318274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure"],"prefix":"10.1038","volume":"12","author":[{"given":"Kenji","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Kagiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"6032_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ejhf.74","volume":"16","author":"RJ Mentz","year":"2014","unstructured":"Mentz, R. J. et al. Decongestion in acute heart failure. Eur. J. Heart Fail. 16, 471\u2013482. https:\/\/doi.org\/10.1002\/ejhf.74 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"6032_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy, C. W. et al. 2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128, 1810\u20131852. https:\/\/doi.org\/10.1161\/CIR.0b013e31829e8807 (2013).","journal-title":"Circulation"},{"key":"6032_CR3","doi-asserted-by":"publisher","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18, 891\u2013975 (2016). https:\/\/doi.org\/10.1002\/ejhf.592.","DOI":"10.1002\/ejhf.592"},{"key":"6032_CR4","doi-asserted-by":"publisher","unstructured":"Felker, G. M., O'Connor, C. M., Braunwald, E. & Heart Failure Clinical Research Network. Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ. Heart Fail. 2, 56\u201362 (2009). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.108.821785.","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785"},{"key":"6032_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1005419","volume":"364","author":"GM Felker","year":"2011","unstructured":"Felker, G. M. et al. Diuretic strategies in patients with acute decompensated heart failure. N. Engl. J. Med. 364, 797\u2013805. https:\/\/doi.org\/10.1056\/NEJMoa1005419 (2011).","journal-title":"N. Engl. J. Med."},{"key":"6032_CR6","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","volume":"69","author":"Y Matsue","year":"2017","unstructured":"Matsue, Y. et al. Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure. J. Am. Coll. Cardiol. 69, 3042\u20133051. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.042 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"6032_CR7","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ejhf.170","volume":"16","author":"AA Voors","year":"2014","unstructured":"Voors, A. A. et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome: an analysis from RELAX-AHF. Eur. J. Heart Fail. 16, 1230\u20131240. https:\/\/doi.org\/10.1002\/ejhf.170 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"6032_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cardfail.2018.09.004","volume":"25","author":"S Kuroda","year":"2019","unstructured":"Kuroda, S. et al. Very early diuretic response after admission for acute heart failure. J. Card. Fail. 25, 12\u201319. https:\/\/doi.org\/10.1016\/j.cardfail.2018.09.004 (2019).","journal-title":"J. Card. Fail."},{"key":"6032_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","volume":"13","author":"SW Oh","year":"2015","unstructured":"Oh, S. W. & Han, S. Y. Loop diuretics in clinical practice. Electrolyte Blood Press. 13, 17\u201321. https:\/\/doi.org\/10.5049\/EBP.2015.13.1.17 (2015).","journal-title":"Electrolyte Blood Press."},{"key":"6032_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ehf2.12103","volume":"3","author":"M Konishi","year":"2016","unstructured":"Konishi, M. et al. Heart failure epidemiology and novel treatments in Japan: facts and numbers. ESC Heart Fail. 3, 145\u2013151. https:\/\/doi.org\/10.1002\/ehf2.12103 (2016).","journal-title":"ESC Heart Fail."},{"key":"6032_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ehf2.12305","volume":"5","author":"TD Tanaka","year":"2018","unstructured":"Tanaka, T. D., Sawano, M., Ramani, R., Friedman, M. & Kohsaka, S. Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence. ESC Heart Fail. 5, 931\u2013947. https:\/\/doi.org\/10.1002\/ehf2.12305 (2018).","journal-title":"ESC Heart Fail."},{"key":"6032_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/01.cir.88.1.107","volume":"88","author":"KK Ho","year":"1993","unstructured":"Ho, K. K., Anderson, K. M., Kannel, W. B., Grossman, W. & Levy, D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 88, 107\u2013115. https:\/\/doi.org\/10.1161\/01.cir.88.1.107 (1993).","journal-title":"Circulation"},{"key":"6032_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jchf.2018.09.008","volume":"7","author":"RB Patel","year":"2019","unstructured":"Patel, R. B. et al. History of atrial fibrillation and trajectory of decongestion in acute heart failure. JACC Heart Fail. 7, 47\u201355. https:\/\/doi.org\/10.1016\/j.jchf.2018.09.008 (2019).","journal-title":"JACC Heart Fail."},{"key":"6032_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cardfail.2004.02.011","volume":"10","author":"GM Felker","year":"2004","unstructured":"Felker, G. M. et al. Risk stratification after hospitalization for decompensated heart failure. J. Card. Fail. 10, 460\u2013466. https:\/\/doi.org\/10.1016\/j.cardfail.2004.02.011 (2004).","journal-title":"J. Card. Fail."},{"key":"6032_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10741-014-9442-y","volume":"19","author":"PL Santaguida","year":"2014","unstructured":"Santaguida, P. L. et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review. Heart Fail. Rev. 19, 453\u2013470. https:\/\/doi.org\/10.1007\/s10741-014-9442-y (2014).","journal-title":"Heart Fail. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06032-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06032-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:41:36Z","timestamp":1669329696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06032-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6032"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06032-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Takahoro Okumura received honoraria from Ono Yakuhin, Novartis, AstraZeneca, and Otsuka, and research grants from Ono Yakuhin, Amgen Astellas, Pfizer, Alexion, and Alnylam (not in connection with the submitted work). Dr Keisuke Kida received honoraria from Daichi Sankyo Co., Ono Yakuhin, AstraZeneca, Otsukaand Novartis. Dr. Nobuyuki Kagiyama is affiliated with a department funded by Philips Healthcare, Asahi KASEI Corporation, Inter Reha Co., Ltd, and Toho Holdings Co., Ltd based on collaborative research agreement. Dr. Yuya Matsue is affiliated with a department endowed by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi. Dr. Yuya Matsue received honorariums from Otsuka Pharmaceutical Co. and Novartis Japan. The remaining authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2127"}}